Peripheral Artery Disease Diagnosed by Pulse Palpation as a Predictor of Coronary Artery Disease in Patients with Chronic Kidney Disease
Carregando...
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
MDPI
Autores
NATANIEL, Felizardo A.
Citação
JOURNAL OF CLINICAL MEDICINE, v.12, n.18, article ID 5882, 10p, 2023
Resumo
There is a need of simple, inexpensive, and reliable noninvasive testing to predict coronary artery disease (CAD) in patients with chronic kidney disease (CKD), where the prevalence of cardiovascular (CV) events and death is elevated. We analyzed the association between peripheral artery disease (PAD) and CAD in 201 patients with stage 5 CKD on dialysis using a prospective observational cohort. Diagnosis of PAD by both palpation and USD were significantly correlated. In patients with PAD diagnosed by palpation, CAD was observed in 80%, while in those diagnosed by USD, CAD was present in 79.1%. The absence of a pulse by palpation predicted CAD with a sensitivity of 55% and a specificity of 76%; USD showed a sensitivity of 62% and specificity of 60% to predict CAD. The risk of combined serious CV events and death was significantly higher in subjects with PAD diagnosed by palpation, but not by USD. PAD assessed by palpation also correlated with the occurrence of multivessel CAD and with the probability of coronary intervention. Both methods are moderately useful for predicting CAD, but PAD diagnosis by palpation was a better predictor of combined CV events and death and was also associated with CAD severity and likelihood of intervention.
Palavras-chave
chronic kidney disease, peripheral artery disease, coronary artery disease, pulse palpation, doppler ultra sound
Referências
- Amin A, 2013, NUCL MED COMMUN, V34, P314, DOI 10.1097/MNM.0b013e32835ec88a
- Bangalore S, 2020, NEW ENGL J MED, V382, P1608, DOI 10.1056/NEJMoa1915925
- Cho SW, 2015, INT HEART J, V56, P209, DOI 10.1536/ihj.14-284
- De Lima JJG, 2016, TRANSPLANTATION, V100, P1580, DOI 10.1097/TP.0000000000001157
- De Lima JJG, 2018, INT J NEPHROL RENOV, V11, P303, DOI 10.2147/IJNRD.S174018
- Furuhashi T, 2014, CIRC J, V78, P1676, DOI 10.1253/circj.CJ-14-0018
- Hur DJ, 2012, AM J CARDIOL, V110, P736, DOI 10.1016/j.amjcard.2012.04.059
- Hwang JY, 2017, ULTRASONOGRAPHY, V36, P111, DOI 10.14366/usg.16054
- Kanigicherla DAK, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240912
- Kassab K, 2022, J NUCL CARDIOL, V29, P543, DOI 10.1007/s12350-021-02561-6
- Keven A, 2017, J ULTRASON, V17, P235, DOI 10.15557/JoU.2017.0034
- Lioudaki E, 2022, DIAGNOSTICS, V12, DOI 10.3390/diagnostics12102332
- Maini R, 2018, J AM SOC NEPHROL, V29, P2782, DOI 10.1681/ASN.2018070674
- Matsushita K, 2022, NAT REV NEPHROL, V18, P696, DOI 10.1038/s41581-022-00616-6
- Morooka H, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-042315
- Seixas EDA, 2015, RENAL FAILURE, V37, P597, DOI 10.3109/0886022X.2015.1007822
- Seliger SL, 2003, KIDNEY INT, V64, P603, DOI 10.1046/j.1523-1755.2003.00101.x
- Serra R, 2021, INT J GEN MED, V14, P3749, DOI 10.2147/IJGM.S322417
- Smith SC, 2006, CIRCULATION, V113, P2363, DOI 10.1161/CIRCULATIONAHA.106.174516
- Steinmetz T, 2022, FRONT CARDIOVASC MED, V9, DOI 10.3389/fcvm.2022.974158
- Vijayan Swati, 2022, Korean J Transplant, V36, P187, DOI 10.4285/kjt.22.0029
- Wang LW, 2011, AM J KIDNEY DIS, V57, P476, DOI 10.1053/j.ajkd.2010.11.018
- Gowdak LHW, 2013, TRANSPLANT RES, V2, DOI 10.1186/2047-1440-2-18